![James Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Kelly
Finanzdirektor/CFO bei
NOVAVAX, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Gegenwärtig ist James Patrick Kelly Chief Financial Officer, Treasurer und Executive VP von Novavax, Inc. Er ist außerdem Mitglied der Association of Bioscience Financial Officers. In seiner früheren Laufbahn war er Chief Financial Officer, Treasurer & Executive VP bei Vanda Pharmaceuticals, Inc. sowie Chief Financial Officer & Executive Vice President bei Supernus Pharmaceuticals, Inc. und Director-Planning & Operations bei Biogen, Inc. sowie Vice President & Controller bei Aetna, Inc. und MedImmune LLC. Herr Kelly erwarb einen MBA an der Cornell University und einen Bachelor-Abschluss an der University of Vermont.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NOVAVAX, INC. 0.08% | 23.04.2026 | 130’599 ( 0.08% ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von James Kelly
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVAVAX, INC. | Finanzdirektor/CFO | 16.08.2021 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von James Kelly
| Unternehmen | Position | Ende |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 13.08.2021 |
| VANDA PHARMACEUTICALS INC. | Finanzdirektor/CFO | 15.03.2020 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Comptroller/Controller/Auditor | 01.12.2010 |
| BIOGEN INC. | Corporate Officer/Principal | 01.11.2005 |
| AETNA | Corporate Officer/Principal | 01.06.2000 |
Ausbildung von James Kelly
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Aetna, Inc.
 Aetna, Inc. Managed Health CareHealth Services Provides health insurance plans services | Health Services |
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Commercial Services |
